FDA Inspection
Topiderm Inc.Topiderm Inc. – FDA Inspection, May 13, 2014
Record Details
This FDA Inspection record concerns Topiderm Inc., with an inspection on May 13, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Topiderm Inc.
- Inspection Date
- May 13, 2014
- Product Type
- Drugs
View Company Profile
ID · 0af62658-b39c-42bb-941c-d583806499b9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 878235
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.100(a)Approval and review of procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Topiderm Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | VAI | New York District Office | Drug Quality Assurance |
| October 9, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 21, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 2, 2013 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Topiderm Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.